Please Wait
Applying Filters...
menu
    • menu
    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Casdatifan

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arcus Bio Reveals Q3 2025 Financials And Pipeline Update
    Arcus Bio Reveals Q3 2025 Financials And Pipeline Update

    28 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251028605428/en/Arcus-Biosciences-Reports-Third-Quarter-2025-Financial-Results-and-Provides-a-Pipeline-Update

    BUSINESSWIRE
    28 Oct 2025
    Share Share
    Taiho Pharma Opts For Exclusive License Of Casdatifan In Japan
    Taiho Pharma Opts For Exclusive License Of Casdatifan In Japan

    19 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251019482380/en/Taiho-Pharmaceutical-Exercises-Option-for-an-Exclusive-License-to-Casdatifan-in-Japan-and-Certain-Territories-in-Asia

    BUSINESSWIRE
    19 Oct 2025
    Share Share
    Arcus Presents Casdatifan Data, Reveals New Inflammation Programs
    Arcus Presents Casdatifan Data, Reveals New Inflammation Programs

    06 Oct 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-10-06/arcus-biosciences-presents-new-data-for-its-hif-2a-inhibitor-casdatifan-and-discloses-first-inflamma

    PHARMAWEB
    06 Oct 2025
    Share Share
    Arcus Kidney Cancer Drug Casdatifan Advances to Challenge Welireg
    Arcus Kidney Cancer Drug Casdatifan Advances to Challenge Welireg

    03 Jun 2025

    // BIOSPACE

    https://www.biospace.com/drug-development/arcus-kidney-cancer-drug-casdatifan-advances-to-challenge-mercks-welireg

    BIOSPACE
    03 Jun 2025
    Share Share
    ARC-20: Casdatifan Combo Shows ~50% Response In Kidney Cancer
    ARC-20: Casdatifan Combo Shows ~50% Response In Kidney Cancer

    01 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250601016939/en/Initial-Data-from-the-ARC-20-Study-of-Casdatifan-Plus-Cabozantinib-Showed-Nearly-Half-of-Patients-with-Metastatic-Kidney-Cancer-Had-a-Confirmed-Response

    BUSINESSWIRE
    01 Jun 2025
    Share Share
    Data Demonstrated Best-in-Class Potential for Casdatifan In Kidney Cancer
    Data Demonstrated Best-in-Class Potential for Casdatifan In Kidney Cancer

    18 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250215794589/en

    BUSINESSWIRE
    18 Feb 2025
    Share Share